Cargando…

The race to stymie BTK: zanu zings

Detalles Bibliográficos
Autores principales:	Kapoor, Prashant, Treon, Steven P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2020
Materias:	Blood Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555376/ https://www.ncbi.nlm.nih.gov/pubmed/33119761 http://dx.doi.org/10.1182/blood.2020008197

Ejemplares similares

The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients
por: Treon, Steven P., et al.
Publicado: (2020)

Pirtobrutinib: a new hope for patients with BTK inhibitor–refractory lymphoproliferative disorders
por: Thompson, Philip A., et al.
Publicado: (2023)

Too many unknowns stymie response to MERS
por: Maurice, John
Publicado: (2015)

Argonne : Le projet ZING
Publicado: (1975)

Autophagosome maturation stymied by SARS-CoV-2
por: Yim, Willa Wen-You, et al.
Publicado: (2021)

Argonne: ZING goes 56 million
Publicado: (1975)

Reasons behind stymied public hospital governance reform in China
por: Nong, Sheng, et al.
Publicado: (2019)

TRPA1: An asthma target with a zing
por: Jordt, Sven-Eric
Publicado: (2021)

Argonne: Ultracold neutrons atZING-P'
Publicado: (1980)

Argonne : Neutrons ultrafroids au ZING-P'
Publicado: (1980)

Cooling down VITT with IVIG
por: Lentz, Steven R.
Publicado: (2021)

Tet2 helps blood cells balance in air
por: Chute, John P.
Publicado: (2022)

Zing-Yang Kuo and behavior epigenesis based on animal experiments
por: Qian, Yanyan, et al.
Publicado: (2018)

Another front in COVID-19’s perfect storm
por: Jobe, Shawn M., et al.
Publicado: (2021)

Vaccination against COVID-19: a challenge in CLL
por: Eichhorst, Barbara
Publicado: (2021)

Understanding VITT(ual) reality
por: Rauova, Lubica, et al.
Publicado: (2021)

Boosting BNT162b2 vaccine efficacy in CLL
por: Bhat, Seema A., et al.
Publicado: (2022)

Danger ahead: COVID-19 infections after vaccination
por: Greenberger, Lee M., et al.
Publicado: (2022)

Vaccinations and ITP: keep on track(ing)
por: Bakchoul, Tamam, et al.
Publicado: (2022)

Thrombosis with COVID-19: kids get it too
por: Takemoto, Cliff
Publicado: (2021)

VITT(al) insights into vaccine-related clots
por: Strich, Jeffrey R., et al.
Publicado: (2021)

A tale of two alleles: TP53 and transformation in MPNs
por: Brierley, Charlotte, et al.
Publicado: (2022)

Neutrophils clear sterile inflammatory debris
por: Yost, Christian Con
Publicado: (2021)

Why B(-)other? About the gap of unknowns in ALL
por: Fioretos, Thoas
Publicado: (2022)

CD7 CAR: sword and shield
por: Velasquez, M. Paulina, et al.
Publicado: (2022)

Buckling up against COVID-19 after CAR T-cell therapy
por: Auletta, Jeffery J.
Publicado: (2022)

CLL and COVID-19: light at the end of the tunnel?
por: Scarfò, Lydia, et al.
Publicado: (2022)

Platelets get particular
por: Rauova, Lubica, et al.
Publicado: (2022)

Blood donation motivators and barriers reported by young, first‐time whole blood donors: Examining the association of reported motivators and barriers with subsequent donation behavior and potential sex, race, and ethnic group differences
por: France, Christopher R., et al.
Publicado: (2022)

‘Green Zing’ and a selection of color concept descriptors on IQOS HEETS in Mexico
por: Grilo, Graziele, et al.
Publicado: (2022)

BTK mutations in patients with chronic lymphocytic leukemia receiving tirabrutinib
por: Jackson, Ross A., et al.
Publicado: (2023)

Whole blood donor behavior and availability after deferral: Consequences of a new ferritin monitoring policy
por: Spekman, Marloes L.C., et al.
Publicado: (2020)

Barriers to blood donation on social media: An analysis of Facebook and Twitter posts
por: Ramondt, Steven, et al.
Publicado: (2020)

Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance
por: Ho, Matthew, et al.
Publicado: (2022)

New blood donors in times of crisis: Increased donation willingness, particularly among people at high risk for attracting SARS‐CoV‐2
por: Spekman, Marloes L. C., et al.
Publicado: (2021)

P1679: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) TREATED WITH ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR): RESULTS FROM THE PHASE 3 ASPEN TRIAL LONG-TERM FOLLOW-UP
por: Tedeschi, Alessandra, et al.
Publicado: (2023)

A robust autonomous method for blood demand forecasting
por: Turkulainen, Esa V., et al.
Publicado: (2022)

Predicting vasovagal reactions to a virtual blood donation using facial image analysis
por: Rudokaite, Judita, et al.
Publicado: (2022)

First results of a ferritin‐based blood donor deferral policy in the Netherlands
por: Vinkenoog, Marieke, et al.
Publicado: (2020)

Mitigating the risk of transfusion‐transmitted infections with vector‐borne agents solely by means of pathogen reduction
por: Stramer, Susan L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vv1k4pvhcnso8pu7p43euau7ha